MorphoSys Sustainability Profile
MorphoSys AG, a leading biopharmaceutical company headquartered in Germany, is renowned for its innovative approach in the field of therapeutic antibodies. Founded in 1992, the company has made significant strides in the development of treatments for cancer and autoimmune diseases, establishing a strong presence in Europe and North America. With a focus on proprietary and partnered drug development, MorphoSys has achieved notable milestones, including the successful launch of its flagship product, Monjuvi (tafasitamab), which targets specific forms of lymphoma. The company’s unique technology platforms, such as its Ylanthus® antibody library, enable the rapid discovery of high-quality therapeutic candidates, positioning MorphoSys as a key player in the biopharmaceutical industry. Through its commitment to advancing healthcare, MorphoSys continues to make impactful contributions to patient care and treatment options.
DitchCarbon Score
How does MorphoSys's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MorphoSys's score of 76 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MorphoSys's reported carbon emissions
In 2023, MorphoSys reported total carbon emissions of approximately 18,856,470 kg CO2e. This figure includes Scope 1 emissions of about 101,820 kg CO2e, Scope 2 emissions of approximately 1,340 kg CO2e (market-based), and a significant contribution from Scope 3 emissions, which totalled around 18,753,310 kg CO2e. The Scope 3 emissions breakdown reveals major sources, including capital goods (about 10,204,310 kg CO2e) and business travel (approximately 1,833,700 kg CO2e). In comparison, the previous year, 2022, MorphoSys's total emissions were reported at about 2,236.96 kg CO2e, with Scope 1 emissions at approximately 10,335,000 kg CO2e and Scope 2 emissions at around 1,060.64 kg CO2e. The Scope 3 emissions for that year were about 1,072.96 kg CO2e. MorphoSys has not disclosed specific reduction targets or initiatives in their climate commitments. However, it is important to note that their emissions data is cascaded from their parent company, Novartis AG, through a merged entity relationship. This means that while MorphoSys is responsible for its own emissions reporting, it may align with broader sustainability initiatives and targets set by Novartis AG.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 10,335,000 | 000,000 |
| Scope 2 | 1,060.64 | 0,000 |
| Scope 3 | 1,072.96 | 00,000,000 |
How Carbon Intensive is MorphoSys's Industry?
How Carbon Intensive is MorphoSys's Location?
MorphoSys's Scope 3 Categories Breakdown
MorphoSys's Scope 3 emissions, which increased significantly last year and increased significantly since 2022, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Capital Goods" being the largest emissions source at 54% of Scope 3 emissions.
Top Scope 3 Categories
MorphoSys's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MorphoSys has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
